Frontlight ResearchEarly access
Trial site
Texas Diabetes & Endocrinology, P.A.
- 3running trials
- 6closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Type 2 diabetes5 trials
- Type 1 diabetes2 trials
- Chronic kidney disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Completed6 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company8 trials
- Endogenex, Inc.1 trial
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 12 Nov 2026